Unlikely to cause harm — often a labeling or packaging issue.
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
| Brand name | FESOTERODINE FUMARATE |
| Generic name | FESOTERODINE FUMARATE |
| Active ingredient(s) | FESOTERODINE FUMARATE |
| Distributed by / for | Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA |
| NDC | 62332-176-30 |
| Full product label | Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30 |
| Recalling firm | Alembic Pharmaceuticals Limited |
| Distribution | US Nationwide and PR. |
| Recall initiated | 2025-12-16 |
| Report date | 2026-01-14 |
| Recall completed | — |
| Recall number | D-0248-2026 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Panchmahal India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗